Implant Sciences delivers $1m of explosives trace detectors worldwide

Implant Sciences has delivered QS-B220 desktop explosives and drugs trace detectors and its QS-H150 handheld explosives trace detectors (ETDs) worth approximately $1m.

The deliveries fulfilled additional demand from European nations to strengthen aviation security.

Implant Sciences’ ETDs were selected by airports across 14 EU nations, while more than 1,000 units to support European Civil Aviation Conference (ECAC) regulations.

Implant Sciences executive vice-president Darryl Jones said: "Implant Sciences continues to perform as the market leader, selected time and again by the busiest airports in Europe."

Implant Sciences president Robert Liscouski said: "The importance of having effective aviation security cannot be overstated.

"It is Implant Sciences’ mission to support the safety of passengers as well as the employees of the airports, airlines, and retail stores within the airport."

Incorporating the company’s patented non-radioactive ion mobility spectrometry (IMS) analysis technology, the QS-B220 systems perform real-time detection and identification of trace amounts of different military, commercial and homemade explosives, as well as illicit drugs.

The trace detection systems feature a radioactive material-free design, easy-to-use touchscreen user interface, push-button maintenance and diagnostics and a patented inCal internal automatic calibration system, which prevents errors that could result from an uncalibrated instrument.

With significantly lower maintenance requirements than its competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products.